Manufacturers hoping to market their devices across North America would have one fewer application to complete under a new pilot program from the US Food and Drug Administration and Health Canada.
The joint eStar pilot, which was announced on 10 January, will test the feasibility of allowing sponsors to submit device applications to both agencies in the same eStar format....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?